These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29285812)

  • 21. An international survey on the awareness, use, preference, and health perception of novel psychoactive substances (NPS).
    Deligianni E; Corkery JM; Schifano F; Lione LA
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28485125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New psychoactive substances: Are there any good options for regulating new psychoactive substances?
    Reuter P; Pardo B
    Int J Drug Policy; 2017 Feb; 40():117-122. PubMed ID: 27889115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The harmful effects of drugs as perceived by the Spanish public.
    Del Rio MC; Alvarez FJ
    Addiction; 1995 Aug; 90(8):1113-6. PubMed ID: 7549780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Driving under the influence of drugs: Perceptions and attitudes of New Zealand drivers.
    Malhotra N; Starkey NJ; Charlton SG
    Accid Anal Prev; 2017 Sep; 106():44-52. PubMed ID: 28554064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interim regulated legal market for NPS ('legal high') products in New Zealand: The impact of new retail restrictions and product licensing.
    Wilkins C
    Drug Test Anal; 2014; 6(7-8):868-75. PubMed ID: 24817124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015.
    Domingo-Salvany A; Herrero MJ; Fernandez B; Perez J; Del Real P; González-Luque JC; de la Torre R
    Forensic Sci Int; 2017 Sep; 278():253-259. PubMed ID: 28778032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
    Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
    J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Consumption of psychoactive substances by school-age adolescents of Ribeirão Preto, SP (Brazil). II--Distribution of consumption by social levels].
    Muza GM; Bettiol H; Muccillo G; Barbieri MA
    Rev Saude Publica; 1997 Apr; 31(2):163-70. PubMed ID: 9497564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The New Zealand Psychoactive Substances Act (PSA): a policy breakthrough or just a symbolic act?
    Bretteville-Jensen AL
    Addiction; 2014 Oct; 109(10):1590-1. PubMed ID: 25163706
    [No Abstract]   [Full Text] [Related]  

  • 32. [New psychoactive substances abuse among patients with access to methadone maintenance treatment in Jiangsu province: a case-control study].
    Cheng Z; Chen GH; Dai MM; Luo W; Lyu P; Cao XB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):625-630. PubMed ID: 29860806
    [No Abstract]   [Full Text] [Related]  

  • 33. Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre.
    Hondebrink L; Nugteren-van Lonkhuyzen JJ; Van Der Gouwe D; Brunt TM
    Drug Alcohol Depend; 2015 Feb; 147():109-15. PubMed ID: 25541244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior.
    Vreeker A; van der Burg BG; van Laar M; Brunt TM
    Addict Behav; 2017 Jul; 70():72-78. PubMed ID: 28214739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Visits to the doctor because of illness or injury of the students of vocational schools who consume or do not consume psychoactive substances (comparative aspects)].
    Iurgaĭtene DP; Shopagene DS; Andreev VA
    Ter Arkh; 2012; 84(1):15-8. PubMed ID: 22616526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.
    Morgan CJ; Noronha LA; Muetzelfeldt M; Feilding A; Curran HV
    J Psychopharmacol; 2013 Jun; 27(6):497-506. PubMed ID: 23438502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Fluoroamphetamine in the Netherlands: more than a one-night stand.
    Linsen F; Koning RP; van Laar M; Niesink RJ; Koeter MW; Brunt TM
    Addiction; 2015 Jul; 110(7):1138-43. PubMed ID: 25808511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To prohibit or regulate psychoactive substances: has New Zealand got the right approach?
    Rizwan SB; Vernall AJ
    BMJ; 2017 Mar; 356():j1195. PubMed ID: 28314708
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxicological investigations of drivers killed in road traffic accidents in Norway during 2006-2008.
    Gjerde H; Christophersen AS; Normann PT; Mørland J
    Forensic Sci Int; 2011 Oct; 212(1-3):102-9. PubMed ID: 21665393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.